SMPD1 and Farber lipogranulomatosis: In the context of the sphingolipid metabolic pathway, it is possible that SMPD1 knockout-induced ceramide depletion may counter ceramide accumulation in Farber disease and enhance lifespan in the Gaucher model by shifting complex sphingolipid catabolism toward ceramide instead of psychosine.